1189810-02-3

Basic information

• Product Name: N-(2,4-dichlorophenyl)-N-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide
• Synonyms: N-(2,4-dichlorophenyl)-N-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide
• CAS NO: 1189810-02-3
• Molecular Weight: 404.317
• Mol File: 1189810-02-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(2,4-dichlorophenyl)-N-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2,4-dichlorophenyl)-N-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide(1189810-02-3)
• EPA Substance Registry System: N-(2,4-dichlorophenyl)-N-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide(1189810-02-3)

Safety Data

• Hazardous Substances Data: 1189810-02-3(Hazardous Substances Data)

Upstream product

• 1189815-88-0 4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carbonyl chloride 
• 35113-88-3 N-methyl-2,4-dichloro-aniline 

Relevant articles and documents

BENZOPYRAN AND BENZOXEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE

Benzopyran and benzoxepin compounds of Formulas I and II, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formulas I and II for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.